One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v126.23.1669.1669
Copy DOI Journal: Blood |  Publication Date: Dec 3, 2015 |
 Citations: 15 |
Affiliation: Albert Einstein College of Medicine, University of Florence, Marien Hospital Düsseldorf, Complejo Hospitalario de Salamanca, Praxis für Hämatologie und Onkologie, University Hospital Ulm, University of Eastern Piedmont Amadeo Avogadro, Hospital Universitario Ramón y Cajal, Eli Lilly (United Kingdom), Eli Lilly (United States), Moffitt Cancer CenterPhase 2 Study of Monotherapy Galunisertib (LY2157299 Monohydrate) in Very Low-, Low-, and Intermediate-Risk Patients with Myelodysplastic Syndromes
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
